GlaxoSmithKline Consumer Nigeria Plc manufactures, markets, and distributes a range of consumer healthcare and pharmaceutical products in Nigeria. The company operates through two segments, Consumer Healthcare and Pharmaceuticals. It offers consumer healthcare products, including oral healthcare products for family care, and sensitivity and bleeding gums; wellness products, such as pain management, and gastro-intestinal and respiratory health products, as well as multivitamins; and nutritional healthcare products comprising functional beverages and family nutritions primarily under the Panadol, Andrews Liver Salt, Macleans, Sensodyne, Phensic, Lucozade, and Ribena brands. The company also provides pharmaceutical products comprising prescription drugs for the treatment of asthma, malaria, depression, migraine, diabetes, heart failure, digestive conditions, and cancer; and vaccines to protect against illnesses, such as hepatitis A and B, diphtheria, tetanus, whooping cough, typhoid, influenza, and cervical cancer under the Ampiclox, Amoxil, Augmentin, Zentel, and Halfan brands. The company was formerly known as Beecham Limited. GlaxoSmithKline Consumer Nigeria Plc was incorporated in 1971 and is based in Lagos, Nigeria.
glaxosmithkline consumer nig
(GLAXOSMI:Nigerian Stock Exchange)
1, Industrial Avenue
Phone: 234 1 271 1000
|Albany Molecular Research Inc||$18.79 USD||-0.31|
|AstraZeneca PLC||4,750 GBp||-78.50|
|Merck & Co Inc||$56.88 USD||-0.96|
|Sumitomo Dainippon Pharma Co Ltd||¥1,397 JPY||-28.00|
|Teva Pharmaceutical Industries Ltd||$64.91 USD||+1.42|
|View Industry Companies|
Sponsored Financial Commentaries
To contact GLAXOSMITHKLINE CONSUMER NIG, please visit www.gsk.com/ng. Company data is provided by Capital IQ. Please use this form to report any data issues.